Preview

Fundamental and Clinical Medicine

Advanced search

Population-genetic research of the VDR gene polymorphism

https://doi.org/10.23946/2500-0764-2019-4-2-72-77

Abstract

Aim. To explore the prevalence of alleles and genotypes in rsl544410 polymorphism within the VDR gene in the population of Kemerovo Region.

Materials and Methods. Genotyping was performed in 232 residents of Kemerovo region (125 men and 107 women, average 58,3 ± 1,86 (range 45-74) years of age). DNA was extracted from the peripheral blood utilizing a thermocoagulation method while genotyping was carried out by allele-specific polymerase chain reaction.

Results. Heterozygous (G/A)    rsl544410 genotype prevailed in the studied sample (46.1%). Homozygous genotype A/A associated with the reduced bone mineral density and osteopenia/osteoporosis was defined in 13.8% of individuals. The ratio of rsl544410 genotypes was comparable with that of ethnically close populations.

Conclusion. High population frequency of the A/A genotype of the rsl544410 polymorphism within the VDR gene may be one of the factors determining the high prevalence of osteoporosis in the population of Kemerovo Region.

About the Authors

A. N. Volkov
Kemerovo State Medical University; Kemerovo Regional Clinical Hospital
Russian Federation

Dr. Alexey N. Volkov - PhD, Associate Professor, Department of Biology, Genetics and Parasitology; Senior Researcher, Central Research Laboratory.

22a, Voroshilova Street, Kemerovo, 650056



E. V. Tsurkan
Kemerovo Regional Clinical Hospital
Russian Federation

Dr. Elena V. Tsurkan - MD, Biologist, Unitfor Genetic Counseling.

22, Oktyabrskiy Prospekt, Kemerovo, 650061



References

1. Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis. Clin Ther. 2015; 37 (8): 1837-1850. doi: 10.1016/j.clinthera.2015.06.006.

2. Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Gen Dev. 2006; 20 (18): 2492-2506. doi: 10.1101/gad.l449506.

3. Yoshida T, Stern PH. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012; 41 (3): 557-569. doi: 10.1016/j.ecl.2012.04.003.

4. Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012; 12 (6): 528-547. doi: 10.2174/156802612799436623.

5. Laird E, Ward M, McSorley E, Strain JJ, Wallace J. Vitamin D and bone health; potential mechanisms. Nutrients. 2010; 2 (7): 693-724. doi: 10.3390/nu2070693.

6. Li Y, Xi B, Li K, Wang C. Association between vitamin D receptor gene polymorphisms and bone mineral density in Chinese women. Mol Biol Rep. 2012; 39 (5): 5709-5717. doi: 10.1007/sll033-011-1380-3.

7. Pouresmaeili F, Jamshidi J, Azargashb E, Samangouee S. Association between vitamin D receptor gene BsmI polymorphism and bone mineral density in a population of 146 Iranian women. Cell J. 2013; 15 (1): 75-82.

8. Jia F, Sun RF, Li QH, Wang DX, Zhao F, Li JM, et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a metaanalysis from 26 studies. Genet Test Mol Biomarkers. 2013; 17 (1): 30-34. doi: 10.1089/gtmb.2012.0267.

9. Verkhoturova SV, Tsarenok SU, Gorbunov W, Aksenova ТА. Polymorphism of some genes of bone tissue metabolism (VDR BsmI c.IVS7G>A, LCT 13910 T>C, COL1A 12046 G->T) among the representatives of Russian and Buryat nationalities. Osteoporosis and Bone Diseases. 2017; 20 (1): 3-7. Russian doi: 10.14341/osteo201713-6.

10. Tagieva AN, Smetnik VP, Suhyh GT, Krylov MU, Grechenko AV, Makotkin VA, et al. Studying the role of genes of receptor vitamin D (VDR), estrogen receptor a (ESRa) and al collagen 1 (COLIA1) in the development of postmenopausal osteoporosis. Medical Genetics. 2005; 4 (2): 90-95. Russian

11. Kozlov Al, Vershubskaya GG, Negasheva MA. Polymorphism of vitamin D receptor (VDR) gene in sampling of European Russia and Priuraliye population. Perm Medical Journal. 2016; 33 (5): 60-66. Russian

12. Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol. 2009; 169 (4): 505-514. doi: 10.1093/aje/kwn359.

13. Maylyan EA. The influence of vitamin D receptor gene 283 A>G (BsmI) polymorphism on osteoporosis in postmenopausal women. Medical Bulletin of the Russian South. 2016; 4: 3238. Russian

14. Mostowska A, Lianeri М, Wudarski М, Olesinska М, Jagodzinski РР. Vitamin D receptor gene BsmI, FokI, Apal and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep. 2013; 40 (2): 803-810. doi: 10.1007/sll033-012-2118-6.

15. Correa-Rodrfguez M, Carrillo-Avila JA, Schmidt-Rio Valle J, Gonzalez-Jimenez E, Vargas S, Martin J, et al. Genetic association analysis of vitamin D receptor gene polymorphisms and obesity-related phenotypes. Gene. 2018; 640: 51-56. doi: 10.1016/j.gene.2017.10.029.

16. Colombini A, Brayda-Bruno M, Lombardi G, Croiset SJ, Ceriani C, Buligan C, et al. BsmI, Apal and TaqI polymorphisms in the vitamin D receptor gene (VDR) and association with lumbar spine pathologies: an Italian case-control study. PLoS ONE. 2016; 11 (5): e0155004. doi: 10.1371/journal.pone.0155004.

17. Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001; 85 (2): 171-175. doi: 10.1054/bjoc.2001.1864.

18. Carvalho C, Marinho A, Leal B, Bettencourt A, Boleixa D, Almeida I, et al. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus. 2015; 24 (8): 846-853. doi: 10.1177/0961203314566636.


Review

For citations:


Volkov A.N., Tsurkan E.V. Population-genetic research of the VDR gene polymorphism. Fundamental and Clinical Medicine. 2019;4(2):72-77. (In Russ.) https://doi.org/10.23946/2500-0764-2019-4-2-72-77

Views: 693


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2500-0764 (Print)
ISSN 2542-0941 (Online)